Oncolytics Biotech Inc T.ONC

BMS enters into a USD$ 2 Billion with startup company

[Noteable]

August 10, 2022 -  Bristol Myers Squibb is doubling down on treating the condition with a nearly $2 billion partnership with GentiBio to develop Treg therapies for patients with IBD.

GentiBio launched last year with a technology platform aimed at combining Tregs biology and antigen receptor engineering.

https://www.biospace.com/article/bms-bets-up-to-1-9-billion-on-gentibio-s-treg-approach-to-treating-ibd/

[Noteable]

Should read:  BMS enters into a USD$ 2 Billion deal with startup company

[Lesalpes29]

No more blah blah blah... NR from onc is what we need!

[fox7mf]

100% agreed. Let's get an NR followed by posts about Oncy being acquired or partnered. BP is throwing massive amounts of cash around, but none towards us...yet. Reading about start-ups and preclinical companies getting multi billions is getting unnerving. Coffey...Parsons...get the sale done!!

[Buckhenry]

But we would not have anything to read on here if we restricted it to oncy only?? ???

[Lesalpes29]

You understand very well what I think.

[Noteable]

Unfortunately the mining and oil/gas purists here would prefer to avoid the usefullness of comparables which serve to illustrate that Big Pharma is confronting a looming patent cliff and is will to pay $Billions for startup companies. Imagine what these same Big Pharma companies are willing to pay for the acquisition of mid-late stage biotech companies with "bolt-on" assets. PwC has

[fox7mf]

Geeez, I wasn't trying to spark a whole brouhaha here...I'm not sure anybody was. I'm on record for being super bullish on Onc. Noteable, I'm also in agreement with your $8b-$15busd assessment of Oncy's value at acquisition. I'm just a little weary of all the BP spending not involving us.

[Noteable]

There is no need to strategize when Big Pharma companies are acquiring 2 year old start-up companies for USD$ 2+ Billion